These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8856186)

  • 41. Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.
    Kodama J; Uchida K; Yoshimura S; Katayama Y; Kushiro H; Yutani C; Funahashi S; Takamiya O; Matsumoto Y; Ando Y
    Blut; 1984 Nov; 49(5):405-18. PubMed ID: 6388669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cascade systems in posttraumatic pulmonary insufficiency.
    Risberg B; Heideman M
    Acta Chir Scand Suppl; 1980; 499():107-11. PubMed ID: 6935890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hereditary angioedema].
    Zusserman MG; Reyes PA
    Alergia; 1984; 31(1):7-11. PubMed ID: 6375439
    [No Abstract]   [Full Text] [Related]  

  • 45. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.
    Schneider L; Lumry W; Vegh A; Williams AH; Schmalbach T
    J Allergy Clin Immunol; 2007 Aug; 120(2):416-22. PubMed ID: 17559913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of the kallikrein-kinin system in acute phase of hemorrhagic and septic shock.
    Miyamoto M; Sudo T; Kawamura M; Ishiyama K; Kuyama T; Kakutani T
    Nihon Geka Hokan; 1989 Nov; 58(6):475-84. PubMed ID: 2519183
    [No Abstract]   [Full Text] [Related]  

  • 47. Crosstalk of the plasma contact system with bacteria.
    Nickel KF; Renné T
    Thromb Res; 2012 Oct; 130 Suppl 1():S78-83. PubMed ID: 23026673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hypertension in pregnancy, preeclampsia].
    Notake Y; Kozuka K; Ideura T
    Nihon Rinsho; 1992 May; 50 Suppl():715-22. PubMed ID: 1513019
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of a short maximal physical exercise on coagulation, fibrinolysis, and complement system.
    Dufaux B; Order U; Liesen H
    Int J Sports Med; 1991 Jun; 12 Suppl 1():S38-42. PubMed ID: 1716617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological effects and the mechanism of complement activation--interaction among complement, coagulation, fibrinolysis and kinin generation system].
    Kondo M; Takemura S
    Nihon Rinsho; 1979 May; 37(5):1038-43. PubMed ID: 381718
    [No Abstract]   [Full Text] [Related]  

  • 51. Clivarin and other LMWHs in an ex vivo cardiopulmonary bypass model. Studies on contact activation.
    Heller W; Wendel HP
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S45-54. PubMed ID: 8180329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.
    Bork K
    Immunol Allergy Clin North Am; 2006 Nov; 26(4):709-24. PubMed ID: 17085286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiographic contrast media and the coagulation and complement systems.
    Hoffmeister HM; Heller W
    Invest Radiol; 1996 Sep; 31(9):591-5. PubMed ID: 8877497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
    Smith MA; Kerr MA
    Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The kinetics of blood coagulability: fibrinolytic and kallikrein-kinin system at the onset and during labor.
    Suzuki S; Sakamoto W
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):209-18. PubMed ID: 6564040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
    Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
    J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.
    Eisen V; Loveday C
    Br J Pharmacol; 1973 Dec; 49(4):678-87. PubMed ID: 4788038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of the hemostatic system during cardiopulmonary bypass.
    Sniecinski RM; Chandler WL
    Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.